{"title":"评估伊朗乳腺癌护理质量指标；多中心研究。","authors":"Mojtaba Vand Rajabpour, Monireh Sadat Seyyedsalehi, Azin Nahvijou, Saeed Nemati, Shaghayegh Haghjooy Javanmard, Amirreza Manteghinejad, Sepideh Abdi, Borna Farazmand, Habibollah Pirnejad, Arash Golpazir Sorkheh, Jamshid Anasari, Masoud Bahrami, Maryam Marzban, Seyedeh Masoumeh Ghoreishi, Yahya Baharvand Iran Nia, Fataneh Bakhshi, Alireza Ansari-Moghaddam, Maryam Moradi Binabaj, Hassan Nourmohammadi, Ramesh Omranipour, Alireza Abdollahi, Mahdi Aghili, Mohammad Ali Mohagheghi, Ali Ghanbari-Motlagh, Partha Basu, Paolo Boffetta, Kazem Zendehdel","doi":"10.1186/s12885-025-14260-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Data on quality-of-care indicators for breast cancer patients is limited in low-and middle-income countries. We evaluated the indicators in Iran.</p><p><strong>Method: </strong>A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.</p><p><strong>Result: </strong>In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.</p><p><strong>Conclusion: </strong>The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"925"},"PeriodicalIF":3.4000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100878/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluating the breast cancer quality of care indicators in Iran; multicenter study.\",\"authors\":\"Mojtaba Vand Rajabpour, Monireh Sadat Seyyedsalehi, Azin Nahvijou, Saeed Nemati, Shaghayegh Haghjooy Javanmard, Amirreza Manteghinejad, Sepideh Abdi, Borna Farazmand, Habibollah Pirnejad, Arash Golpazir Sorkheh, Jamshid Anasari, Masoud Bahrami, Maryam Marzban, Seyedeh Masoumeh Ghoreishi, Yahya Baharvand Iran Nia, Fataneh Bakhshi, Alireza Ansari-Moghaddam, Maryam Moradi Binabaj, Hassan Nourmohammadi, Ramesh Omranipour, Alireza Abdollahi, Mahdi Aghili, Mohammad Ali Mohagheghi, Ali Ghanbari-Motlagh, Partha Basu, Paolo Boffetta, Kazem Zendehdel\",\"doi\":\"10.1186/s12885-025-14260-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Data on quality-of-care indicators for breast cancer patients is limited in low-and middle-income countries. We evaluated the indicators in Iran.</p><p><strong>Method: </strong>A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.</p><p><strong>Result: </strong>In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.</p><p><strong>Conclusion: </strong>The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.</p>\",\"PeriodicalId\":9131,\"journal\":{\"name\":\"BMC Cancer\",\"volume\":\"25 1\",\"pages\":\"925\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100878/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12885-025-14260-3\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-025-14260-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Evaluating the breast cancer quality of care indicators in Iran; multicenter study.
Background: Data on quality-of-care indicators for breast cancer patients is limited in low-and middle-income countries. We evaluated the indicators in Iran.
Method: A total of 21 quality-of-care indicators of breast cancer management defined by EUSOMA 2017 were selected. The indicators were retrospectively evaluated based on the data from the Clinical Breast Cancer Registry established in 11 provinces of Iran.
Result: In the study of 6,293 patients evaluated on 21 indicators, 15 indicators were more than 5% below EUSOMA's standard levels.
Conclusion: The defined indicators had a value lower than the suggested standards by EUSOMA. This study's results highlight important clues for intervention in improving breast cancer outcomes in Iran and other low-and middle-income countries.
期刊介绍：
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
